Alphabet earnings on deck

A look ahead to Alphabet's earnings. And Aimmune Therapeutics jumps as the FDA approves its peanut allergy treatment. With CNBC's Tyler Mathisen and the Fast Money traders, Tim Seymour, Brian Kelly, Steve Grasso and Guy Adami.